Structure of the human class I histocompatibility antigen, HLA-A2 - PubMed (original) (raw)

. 1987 Oct;329(6139):506-12.

doi: 10.1038/329506a0.

Affiliations

• PMID: 3309677
• DOI: 10.1038/329506a0

Structure of the human class I histocompatibility antigen, HLA-A2

P J Bjorkman et al. Nature. 1987 Oct.

Abstract

The class I histocompatibility antigen from human cell membranes has two structural motifs: the membrane-proximal end of the glycoprotein contains two domains with immunoglobulin-folds that are paired in a novel manner, and the region distal from the membrane is a platform of eight antiparallel beta-strands topped by alpha-helices. A large groove between the alpha-helices provides a binding site for processed foreign antigens. An unknown 'antigen' is found in this site in crystals of purified HLA-A2.

PubMed Disclaimer

Similar articles

• The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.
  Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Bjorkman PJ, et al. Nature. 1987 Oct 8-14;329(6139):512-8. doi: 10.1038/329512a0. Nature. 1987. PMID: 2443855
• Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.
  Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, Stuart DI, Bell JI, Jones EY, Jakobsen BK. Gao GF, et al. Nature. 1997 Jun 5;387(6633):630-4. doi: 10.1038/42523. Nature. 1997. PMID: 9177355
• Structural studies on HLA-G: implications for ligand and receptor binding.
  Clements CS, Kjer-Nielsen L, McCluskey J, Rossjohn J. Clements CS, et al. Hum Immunol. 2007 Apr;68(4):220-6. doi: 10.1016/j.humimm.2006.09.003. Epub 2006 Oct 27. Hum Immunol. 2007. PMID: 17400055 Review.
• Natural killer cell recognition of HLA class I molecules.
  Brooks AG, Boyington JC, Sun PD. Brooks AG, et al. Rev Immunogenet. 2000;2(3):433-48. Rev Immunogenet. 2000. PMID: 11256749 Review.

Cited by

• Intracellular checkpoints for NK cell cancer immunotherapy.
  Huang Y, Tian Z, Bi J. Huang Y, et al. Front Med. 2024 Sep 28. doi: 10.1007/s11684-024-1090-6. Online ahead of print. Front Med. 2024. PMID: 39340588 Review.
• MDM2 inhibitors in cancer immunotherapy: Current status and perspective.
  Zeng Q, Zeng S, Dai X, Ding Y, Huang C, Ruan R, Xiong J, Tang X, Deng J. Zeng Q, et al. Genes Dis. 2024 Mar 28;11(6):101279. doi: 10.1016/j.gendis.2024.101279. eCollection 2024 Nov. Genes Dis. 2024. PMID: 39263534 Free PMC article. Review.
• Mononuclear Phagocytes, Cellular Immunity, and Nobel Prizes: A Historic Perspective.
  Gordon S, Roberti A, Kaufmann SHE. Gordon S, et al. Cells. 2024 Aug 19;13(16):1378. doi: 10.3390/cells13161378. Cells. 2024. PMID: 39195266 Free PMC article. Review.
• Structural and biochemical analysis of highly similar HLA-B allotypes differentially associated with type 1 diabetes.
  Sharma R, Amdare NP, Ghosh A, Schloss J, Sidney J, Garforth SJ, Lopez Y, Celikgil A, Sette A, Almo SC, DiLorenzo TP. Sharma R, et al. J Biol Chem. 2024 Sep;300(9):107702. doi: 10.1016/j.jbc.2024.107702. Epub 2024 Aug 22. J Biol Chem. 2024. PMID: 39173948 Free PMC article.
• Implications of MHC-restricted immunopeptidome in transplantation.
  Zhanzak Z, Cina D, Johnson AC, Larsen CP. Zhanzak Z, et al. Front Immunol. 2024 Jul 5;15:1436233. doi: 10.3389/fimmu.2024.1436233. eCollection 2024. Front Immunol. 2024. PMID: 39035001 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program